Device Trial Radar · NCT03898960
Post Marketing Study to Evaluate the NIMBUS Device
Last checked: Nov 20, 2026Latest source record: Apr 25, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
54
Actual
Start
Oct 30, 2019
Primary completion
Feb 15, 2022
Study completion Apr 8, 2022
Sponsor
- Lead sponsor
- Neuravi LimitedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 2, 2019
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A post-market study evaluating the NIMBUS Device in acute ischemic stroke patients with confirmed intracranial large vessel occlusion.
Conditions
- Cerebral Stroke
Interventions
NIMBUS DeviceDevice
NIMBUS Geometric Clot Extractor
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Successful Revascularization With NIMBUS DeviceTime frame: Day 1
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
UKE Hamburg
Hamburg, Germany
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.